Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Effectiveness Study of Paromomycin IM Injection (PMIM) for the Treatment of Visceral Leishmaniasis (VL) in Bangladesh

NCT01328457 is registered in ClinicalTrials.gov with PATH as lead sponsor.

NCT NCT01328457
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01328457 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Effectiveness Study of Paromomycin IM Injection (PMIM) for the Treatment of Visceral Leishmaniasis (VL) in Bangladesh
Lead sponsor
PATH
Phase
Not applicable
Overall status
Completed
Start date
January 31, 2011
Completion date
June 30, 2012
Enrollment
120 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

visceral leishmaniasis